Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
Peer-reviewed research points to the extracellular matrix, the framework that holds tissue together, as central to that work. More than a decade of research has gone into Conexeu’s CXU™ Platform Highlights Regenerative aesthetics has become a $1.6 billion market of its own, and analysts see double-digit growth ahead.¹, ² Medical research confirms it: regeneration is […]
Conexeu Sciences Inc., a preclinical-stage biotechnology company, has identified a new category forming within medical aesthetics, driven by research into regenerative tissue restoration. This emerging field diverges from traditional approaches that focus solely on replacing lost volume, instead exploring methods to restore, rebuild, enhance, and contour soft tissue.
Conexeu believes this opportunity encompasses various applications such as facial rejuvenation, age-related tissue changes, post-weight-loss restoration, soft-tissue enhancement, and body contouring. These areas are gaining popularity as patients increasingly seek natural-looking outcomes through biological restoration.
Brief written by urgent.news from Financial Post's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
